Resultado de búsqueda
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination ...
- 4
- Heather Kirby
- Businesswoman
- West Virginia University (BA)
29 de jul. de 2019 · During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way. And now, Bresch says she's stepping...
- Eric Sagonowsky
Heather Bresch is chief executive officer of Mylan, one of the largest generics and specialty pharmaceutical companies in the world. She also serves on the company’s board of directors. Mylan’s mission is to provide the world’s 7 billion people access to high quality medicine.
17 de mar. de 2022 · Mylan CEO Heather Bresch, left, with her aides during a break of a hearing before the House Committee on Oversight and Reform on Sept. 21, 2016, in Washington, D.C. Photo: Alex Wong/Getty...
7 de sept. de 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new...
- Ryan Grim
In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year. That's partly because Bresch's ...
29 de jul. de 2019 · Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a new...
